Corpus Intelligence IC Memo — CEDAR PARK REGIONAL MEDICAL CENTER 2026-04-26 19:07 UTC
IC Memo — CEDAR PARK REGIONAL MEDICAL CENTER
Investment Committee Memorandum | TX | 115 beds | Grade C | EBITDA uplift $12.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CEDAR PARK REGIONAL MEDICAL CENTER

CCN 670043 | TRAVIS, TX | 115 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CEDAR PARK REGIONAL MEDICAL CENTER is a 115-bed suburban community hospital in TRAVIS, TX with $172.7M in net patient revenue and a 10.1% operating margin. The hospital serves a payer mix of 20.3% Medicare, 5.4% Medicaid, and 74.3% commercial.

Thesis: Turnaround. Our ML models identify $12.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.1% to 17.5% (+736bps).

Net Revenue HCRIS$172.7M
Current EBITDA COMPUTED$17.5M
Operating Margin COMPUTED10.1%
Occupancy HCRIS58.4%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS17.0%
Distress Probability ML44.4%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
187
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 10.1% places it above the state median. Among 187 size-comparable peers (58-230 beds), the median margin is 2.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (58-230), prioritizing same-state peers. 187 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CEDAR PARK REGIONAL MEDICAL CE (Target)TX115$172.7M10.1%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
DELL SETON MEDICAL CENTER AT TTX225$438.6M-4.2%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
MEMORIAL HERMANN KATYTX196$381.4M13.3%
MEMORIAL HERMANN NORTHEASTTX227$381.2M5.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.6M+210bp18mo
Cost to Collect4.5%2.5%$3.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.1M+122bp9mo
Clean Claim Rate88.0%96.0%$110K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.6M
Cost to Collect
$3.5M
Denial Rate Reduction
$3.4M
A/R Days Reduction
$2.1M
Clean Claim Rate
$110K
Total EBITDA Uplift$12.7M
Current EBITDA$17.5M
+ RCM Uplift+$12.7M
Pro Forma EBITDA$30.2M
Current Margin10.1%
Pro Forma Margin17.5%
WC Released (1x)$6.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$26.9M$242.2M9.02x55.3%
Base (11x exit)10.0x11.0x$26.9M$275.2M10.25x59.3%
Bull Case9.0x11.0x$24.2M$325.8M13.48x68.2%
Bull (12x exit)9.0x12.0x$24.2M$362.6M15.00x71.9%
Bear Case11.0x10.0x$29.5M$169.9M5.75x41.9%
Bear (11x exit)11.0x11.0x$29.5M$196.5M6.65x46.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 187 hospitals with 58-230 beds
  • Same-state prioritization (n=188)
  • Comp margins: P25=-9.3% / P50=2.2% / P75=11.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.